PSA定性定量检测在前列腺癌筛选诊断中的对比研究

THE COMPARTIVE STUDY OF QUALITATIVE AND QUANTITATIVE DETECTION OF PSA IN THE DIAGNOSIS OF PROSTATE CANCER

  • 摘要: 目的:探讨快速PSA定性检测诊断前列腺癌的临床价值。方法:运用快速前列腺特异性抗原诊断试剂(一步法)和酶标免疫定量(Tandem-E法)对38例有尿路梗阻症状的BPH病人进行检测,结合病理学诊断对检测结果进行对比分析。结果:快速PSA诊断试剂对前列腺癌诊断有3例假阳性和1例假阴性(以PSA>+为标准),Tandem-E法有2例假阳性和1例假用性(以PSA>4ng/ml为标准),两者符合率为94.74%。结论:快速PSA定性检测可作为前列腺癌筛选诊断快速有效的检测方法.可明显缩短前列腺癌的诊断时间。

     

    Abstract: To evaluate the rapid prostatic specific antigen (PSA) in the diagnosis of piostate cancer. Methods: 33 cases of benign prostatic hyperplasia (BPH) with bladder outflow obstruction (BOO) were assayed by Rapid PSA Test Kit and Enzyme Immunometric Assay Kit respectively. Combined with the pathologic diagnosis, the results were discussed. Results: The results revealed that there were 6 false positive cases and 1 false negative case in the diagnosis of prostate cancer with Rapid PSA Test Kit (According to PSA + ), and 4 false positive cases and 1 false negative case with Tandem - E method (According to PSA4ng/ml). The results were 94. 74 % coincidently with each other. Conclusion: The Rapid PSA Test Kit can be used as a screening method as the Enzyme Immunometic Assay Kit dose in patients who are suspected suffering from prostatic cancer. The rapid one can shorten the diagnostic period greatly.

     

/

返回文章
返回